Pharmaceutical Policy in Countries with Developing Healthcare Systems

1. Introduction.- Section I: Low and Lower Middle Income Countries.- 2. Pharmaceutical Policy in the East African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania.- 3. Pharmaceutical Policy in Pakistan.- 4. Pharmaceutical Policy in Philippines.- 5. Pharmaceutical Policy in Vietnam.- Section II: Upper Middle Income Countries.- 6. Pharmaceutical Policy in Argentina.- 7. Pharmaceutical Policy in Brazil.- 8. Pharmaceutical Policy In Bulgaria.- 9. Pharmaceutical Policy in China.- 10. Pharmaceutical Policy in Colombia.- 11. Pharmaceutical Policy in Ecuador.- 12. Pharmaceutical Policy in Jordan.- 13. Pharmaceutical Policy in Russia.- 14. Pharmaceutical Policy in South Africa.- Section III: High Income Countries.- 15. Pharmaceutical Policy in Poland.- 16. Pharmaceutical Policy in Saudi Arabia.- 17. Pharmaceutical Policy in Trinidad and Tobago.- 18. Pharmaceutical Policy in United Arab Emirates.- Section IV: Further Perspectives.- 19. 'Repurposing' Medicines: a Case for Low- and Middle-Income Countries with Developing Healthcare Systems.- 20. Pharmaceutical Policy in Countries with Developing Healthcare Systems: Synthesis of Country Case Studies.

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare at the Department of Pharmacy, University of Huddersfield, United Kingdom.

He is globally recognized for his research in pharmaceutical policy and practice, including the quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. Previously he was the Head of Pharmacy Practice at School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a Ph.D. in pharmacy practice, Dr. Babar is the recipient of prestigious "Research Excellence Award" from the University of Auckland.

He has active research collaborations and linkages in over 30 countries including in World's leading Universities such as Boston University School of Public Health, Harvard Medical School, Austrian Health Institute, University of Auckland, Monash University and at the University of Sydney. He has published over 150 papers, book chapters, conference papers including in high impact journals such as PLoS Medicine and in Lancet Oncology. Dr. Babar has acted as an advisor for World Health Organization, Health Action International, the International Union Against Tuberculosis and Lung Disease, World Bank, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand.

His recent work includes a number of high-quality books including "Economic evaluation of pharmacy services", "Pharmaceutical prices in 21st century", " Pharmacy Practice Research Methods" and "Pharmaceutical policies in countries with developing healthcare systems. Published by Elsevier and Adis/Springer, the work is used in curriculum design, policy development and for referral all around the globe.

He is the Editor- in- Chief of Encyclopedia of Pharmacy Practice and Clinical Pharmacy, which is due to be published by Elsevier in early 2019.The Encyclopedia aims to cover multiple